Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Benito

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
Journal of Clinical Lipidology|September 23, 2020
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity studyBertha Araceli Marin-Alejandre, Itziar Abete, J Ignacio Monreal, et al.
Journal of Endocrinological Investigation|November 16, 2024
Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary interventionAna Luz Tobaruela-Resola, José Ignacio Riezu-Boj, Fermín I Milagro, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic CohortMax Seidensticker, Ingo G Steffen, Irene Bargellini, et al.
Human Gene Therapy|February 16, 2011
Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primatesAstrid Pañeda, Maria Collantes, Stuart G Beattie, et al.
Nutrients|June 19, 2024
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional InterventionAna Luz Tobaruela-Resola, José I Riezu-Boj, Fermin I Milagro, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 11, 2024
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trialPaola Mogna-Peláez, José I Riezu-Boj, Fermin I Milagro, et al.
Hepatology (Baltimore, Md.)|February 16, 2012
Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis BItziar Otano, Lester Suarez, Javier Dotor, et al.
Journal of the American Heart Association|August 7, 2014
Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosisJulio Madrigal-Matute, Jes Sandal Lindholt, Carlos Ernesto Fernandez-Garcia, et al.
Diagnostics (Basel, Switzerland)|November 11, 2020
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) StudyCristina Galarregui, Bertha Araceli Marin-Alejandre, Nuria Perez-Diaz-Del-Campo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumorsBruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
Journal of Clinical Lipidology|September 23, 2020
Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity studyBertha Araceli Marin-Alejandre, Itziar Abete, J Ignacio Monreal, et al.
Journal of Endocrinological Investigation|November 16, 2024
Circulating microRNA panels in subjects with metabolic dysfunction-associated steatotic liver disease after following a 2-year dietary interventionAna Luz Tobaruela-Resola, José Ignacio Riezu-Boj, Fermín I Milagro, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic CohortMax Seidensticker, Ingo G Steffen, Irene Bargellini, et al.
Human Gene Therapy|February 16, 2011
Adeno-associated virus liver transduction efficiency measured by in vivo [18F]FHBG positron emission tomography imaging in rodents and nonhuman primatesAstrid Pañeda, Maria Collantes, Stuart G Beattie, et al.
Nutrients|June 19, 2024
Multipanel Approach including miRNAs, Inflammatory Markers, and Depressive Symptoms for Metabolic Dysfunction-Associated Steatotic Liver Disease Diagnosis during 2-Year Nutritional InterventionAna Luz Tobaruela-Resola, José I Riezu-Boj, Fermin I Milagro, et al.
Clinical Nutrition (Edinburgh, Scotland)|June 11, 2024
Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trialPaola Mogna-Peláez, José I Riezu-Boj, Fermin I Milagro, et al.
Hepatology (Baltimore, Md.)|February 16, 2012
Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis BItziar Otano, Lester Suarez, Javier Dotor, et al.
Journal of the American Heart Association|August 7, 2014
Galectin-3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosisJulio Madrigal-Matute, Jes Sandal Lindholt, Carlos Ernesto Fernandez-Garcia, et al.
Diagnostics (Basel, Switzerland)|November 11, 2020
Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) StudyCristina Galarregui, Bertha Araceli Marin-Alejandre, Nuria Perez-Diaz-Del-Campo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumorsBruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
Pageof 16